Velan Inc. (VLN)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 17.10 |
|---|---|
| 52-week range | 13.61 – 19.50 |
| Return, 1 month / 3 months | −5.0% / −2.2% |
| Return, 1 year / 3 years | +9.5% / +214.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 32.5% |
| Worst drawdown (1 year) | -26.2% |
| Average daily value traded | 0.10M CAD |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Velan Inc. is an industrial valve manufacturer based in Montreal, Quebec. The company designs and makes gate, globe, check, ball, butterfly and knife gate valves, along with related products such as steam traps and strainers. Its customers come from industries including power generation, oil and gas, chemicals, pulp and paper, and marine shipping, and it supplies both custom-engineered and standard valves for demanding applications. Velan operates manufacturing plants and sales offices in several countries and serves customers around the world.
On this site Velan Inc. appears as a stock on the Toronto Exchange (Canada), code VLN, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Velan Inc. (VLN) trades on the Toronto Exchange in Canada. It last closed at CAD 17.10 on 23 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 439 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.5% and over the last three months it fell 2.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.9% | ||
| From 52-week high | -11.4% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.2% | ||
| 6-month return | 10.3% | ||
| 12-month return, skipping the last month | 15.3% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.2% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.10M CAD | ||
| Zero-volume days | 20.0% | ||
| Income | 13 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −5.0% |
| 3 months | −2.2% |
| 6 months | +10.3% |
| 1 year | +9.5% |
| 3 years | +214.5% |
| 5 years | +117.0% |
Signals
| 50-day / 200-day average | 18.18 / 16.61 |
|---|---|
| Golden / death cross (60 days) | Golden, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Nov 2025 | CAD 0.1000 |
| 15 Aug 2025 | CAD 0.1000 |
| 16 Jun 2025 | CAD 0.3300 |
| 14 Feb 2025 | CAD 0.0300 |
| 15 Jun 2023 | CAD 0.0300 |
| 16 Jun 2022 | CAD 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.